Leben granted therapeutic-use exemption for opioid
It is becoming more common for athletes to be granted a therapeutic-use expemption for testerone by athletic commissions, but at UFC 162 was the first known case of an exemption for a different drug, this time a prescription opioid for Chris Leben:
The Nevada State Athletic Commission issued no new therapeutic-use exemptions for testosterone replacement therapy at UFC 162 but did give UFC middleweight Chris Leben permission to use the prescription opioid medication Suboxone.
Leben (22-10 MMA, 12-9 UFC), who lost a split decision to Andrew Craig (9-1 MMA, 3-1 UFC) at this past Saturday’s event, is the first fighter to receive an exemption for the drug, which typically is used as a replacement therapy for people with narcotic dependency.
NSAC Executive Director Keith Kizer confirmed the news today with MMAjunkie.com (www.mmajunkie.com). Leben was unreachable for comment.